Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Study Location:

Find another location


Questions to ask
Skip to Main Content

Keep up to date

Sign up for news and information about taking part and shaping research.

English | Cymraeg
Be Part of Research - Trial Details - A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)
Back

A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)

Completed

Open to: All Genders

Age: 50 Years - 80 Years

Bath Brentford Brighton Glasgow London, GT LON London Southampton Southampton Swindon

Medical Conditions

Alzheimer's Disease

This information is provided directly by researchers and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information.


This is a Phase II, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the safety and efficacy of MABT5102A in patients with mild to moderate Alzheimer's Disease.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Apr 2011 Feb 2014

Interventional

Intervention Type : Drug
Intervention Description : Repeating subcutaneous injection

Intervention Arm Group : Part 1: Subcutaneous cohort exp

Intervention Type : Drug
Intervention Description : Repeating intravenous infusion

Intervention Arm Group : Part 2: Intravenous cohort exp

Intervention Type : Drug
Intervention Description : Repeating subcutaneous injection

Intervention Arm Group : Part 1: Subcutaneous cohort

Intervention Type : Drug
Intervention Description : Repeating intravenous infusion

Intervention Arm Group : Part 2: Intravenous cohort



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • The Rice Centre; Royal United Hospital
    Bath
    BA1 3NG
  • West London Research Unit; Brentford Lodge
    Brentford
    TW8 8DS
  • Royal Sussex County Hospital, CIRU Level 5
    Brighton
    BN2 5BE
  • Glasgow Memory Clinic
    Glasgow
    G20 0XA
  • The National Hospital for Neurology & Neurosurgery; Dementia Research Center
    London, GT LON
    WC1N 3BG
  • Camden Mews Day Hospital; Camden and Islington
    London
    NW1 9DB
  • Southampton General Hospital; Pharmacy
    Southampton
    SO16 6YD
  • Moorgreen Hospital; Memory Assessment & Rsch Ctr
    Southampton
    SO30 3JB
  • Great Western Hosp.; Kingshill Research Ctr
    Swindon
    SN3 6BW


The study is sponsored by Genentech, Inc.



We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: NCT01343966
Last updated 10 July 2017

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top